Pyridine-2-carboximidamide hydrochloride

HCID 12403615CAS 51285-26-8

Teilstruktursuche Ähnliche Strukturen suchen

Grundinformationen

Standard-SMILES: Cl.N=C(N)c1ccccn1
InChIKey: GMHCEDDZKAYPLB-UHFFFAOYSA-N
Summenformel: C6H8ClN3
Durchschnittliche Molmasse: 157,6 g/mol
Monoisotopische Masse: 157,040675

Namen und Bezeichner

Bevorzugter Name: Pyridine-2-carboximidamide hydrochloride
IUPAC: pyridine-2-carboximidamide;hydrochloride
Englischer Name: Pyridine-2-carboximidamide hydrochloride
Summenformel: C6H8ClN3
Molmasse: 157.6

Namen und Synonyme

pyridine-2-carboximidamide hydrochlorideRefChem:870733676-441-351285-26-8picolinimidamide hydrochloride2-Amidinopyridine hydrochloridePyridine-2-carboxamidine hydrochlorideMFCD00052271pyridine-2-carboximidamide;hydrochloridePICOLINAMIDINE HYDROCHLORIDE2-AMIDINOPYRIDINIUM CHLORIDE61097-49-2

Weitere Namen anzeigen

2-AmidinopyridineBUTTPARK 32\03-542-AmidinopyridiniumHClhydratePyridin-2-carboximidamide HClPyridine-2-carboximidamide, HCl

Pyridine-2-carboxamidine HCl2-Pyridinecarboximidamide, monohydrochloride2-PYRIDINECARBOXIMIDAMIDE HYDROCHLORIDEPICOLINAMIDINE HCLPICOLINIMIDAMIDE HCLpicolinimidamidehydrochloridePicolinimidamide xhydrochlorideSCHEMBL857460

Datenbank-Bezeichner

CAS: 51285-26-8
PubChem CID: 12403615
DTXSID: DTXSID30496598
EC Number: 676-441-3

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA): 62,8 Å²
H-Brücken-Donoren: 3
H-Brücken-Akzeptoren: 2
Frei drehbare Bindungen: 1
Schwere Atome: 10
Formalladung: 0
Komplexität: 111

Physikochemische Eigenschaften

Schmelzpunkt: 150 · 150-152°C
storage temp.: Inert atmosphere,Room Temperature
Aggregatzustand: crystals
Farbe: Off-white
BRN: 3562671 · 3562671
InChI: InChI=1S/C6H7N3.ClH/c7-6(8)5-3-1-2-4-9-5;/h1-4H,(H3,7,8);1H
InChIKey: GMHCEDDZKAYPLB-UHFFFAOYSA-N
SMILES: C(C1N=CC=CC=1)(N)=N.Cl
CAS Datenbank: 51285 · 51285-26-8(CAS DataBase Reference)

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 5 Einträge

Warning

H302+H312+H332 (12.5%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]；H302 (12.5%): Harmful if swallowed [Warning Acute toxicity, oral]；H312 (12.5%): Harmful in contact with skin [Warning Acute toxicity, dermal]；H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]；H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]；H332 (12.5%): Harmful if inhaled [Warning Acute toxicity, inhalation]；H335 (87.5%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 8 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.；Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Gefahrenhinweise

Hazard Classes and CategoriesAcute Tox. 4 (12.5%)；Acute Tox. 4 (12.5%)；Skin Irrit. 2 (100%)；Eye Irrit. 2 (100%)；Acute Tox. 4 (12.5%)；STOT SE 3 (87.5%)

Sicherheitsdaten

hs_code: 29333990
risk_code: 36/37/38
hazard_code: Xi
safety_code: 26-36-37/39-37
hazard_class: IRRITANT

Chemie und Industrie

Anwendungen · 1 Eintrag

VerwendenPyridine-2-carboximidamide hydrochloride serves as a reactant in the synthesis of 1,4-bis[2,6-bis(2-pyridyl)pyrimidin-4-yl]benzene (L1), reacting with 1,4-bis[3-(pyridine-2-yl)propene-1-one]phenylene in ethanol with potassium hydroxide under reflux[6]. As a monoamidine ligand additive, pyridine-2-carboximidamide hydrochloride is incorporated into perovskite precursor solutions to passivate defect sites in the perovskite film[7].